Unlocking the Potential of Pterostilbene: A Pharmaceutical Element for Aptamer-Based Nanomedicine

Xuan Ding, Yu Qin, Thulasiram Bathini, Shangjiu Hu, Xiang Li, Xinyuan Chen, Sijia Xing, Lumin Tang, Yuquan Xie, Shan Mou, Weihong Tan, Ruowen WangACS 2024 · DOI

Abstract

Natural compounds like pterostilbene (PTE) have gained recognition for their various biological activities and potential health benefits. However, challenges related to bioavailability and limited clinical efficacy have prompted efforts to strengthen their therapeutic potential. To meet these challenges, we herein rationally designed and successfully synthesized a pharmaceutical phosphoramidite that allows for the programmable incorporation of PTE into oligonucleotides. The resultant aptamer-PTE conjugate can selectively bind to cancer cells, leading to a specific internalization and drug release. Moreover, compared with free PTE, the conjugate exhibits superior cytotoxicity in cancer cells. Specifically, in a zebrafish xenograft model, the nanomedicine effectively inhibits tumor growth and neovascularization, highlighting its potential for targeted antitumor therapy. This approach presents a promising avenue for harnessing the therapeutic potential of natural compounds via a nanomedicine solution.
BibTeX
@inproceedings{ding2024unlocking,
  author = {Xuan Ding and Yu Qin and Thulasiram Bathini and Shangjiu Hu and Xiang Li and Xinyuan Chen and Sijia Xing and Lumin Tang and Yuquan Xie and Shan Mou and Weihong Tan and Ruowen Wang},
  title = {{Unlocking the Potential of Pterostilbene: A Pharmaceutical Element for Aptamer-Based Nanomedicine}},
  booktitle = {ACS},
  year = {2024},
  doi = {10.1021/acsami.3c16723},
}

Loading related content...

Figure